Showing results (2221-2230 of 2,543) with videos related to

Sort By:
Pageof 255
Clinical Genetics|October 7, 2005
An analysis of PAX1 in the development of vertebral malformationsP F Giampietro, C L Raggio, C E Reynolds, et al.
Cancer Biology & Therapy|August 6, 2010
SILAC-based quantitative proteomic approach to identify potential biomarkers from the esophageal squamous cell carcinoma secretomeManoj Kumar Kashyap, H C Harsha, Santosh Renuse, et al.
Physical Review Letters|December 12, 2001
Observation of plasma focusing of a 28.5 GeV positron beamJ S Ng, P Chen, H Baldis, et al.
Frontiers in Oncology|November 30, 2020
Multi-Omics Analysis to Characterize Cigarette Smoke Induced Molecular Alterations in Esophageal CellsAafaque Ahmad Khan, Krishna Patel, Shankargouda Patil, et al.
Journal of Proteomics|May 19, 2015
LC-MS-based serum metabolomic analysis reveals dysregulation of phosphatidylcholines in esophageal squamous cell carcinomaSartaj Ahmad Mir, Pavithra Rajagopalan, Ankit P Jain, et al.
The Journal of Clinical Endocrinology and Metabolism|May 14, 2013
A comprehensive next generation sequencing-based genetic testing strategy to improve diagnosis of inherited pheochromocytoma and paragangliomaEleanor Rattenberry, Lindsey Vialard, Anna Yeung, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|April 26, 2020
Phosphoproteomic analysis identifies CLK1 as a novel therapeutic target in gastric cancerNiraj Babu, Sneha M Pinto, Manjusha Biswas, et al.
Nature Communications|April 10, 2026
Gallium in liquid state shows nuclease-mimicking activityLi Liu, Jiewei Zheng, Xi Lu, et al.
IJTLD Open|May 14, 2025
Evaluating disability, comorbidities and risk factors after TB treatment: an 18-24 month follow-upY Sun, Y Lin, J E Golub, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 11, 2019
Afatinib versus methotrexate as second-line treatment in Asian patients with recurrent or metastatic squamous cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 3): an open-label, randomised phase III trialY Guo, M-J Ahn, A Chan, et al.
Pageof 255